Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2022
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for ImmunizationElena Bruzzesi, Laura Galli, Andrea Poli, et al.
Journal of the International AIDS Society|November 14, 2014
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in ItalyGiordano Madeddu, Antonella D'Arminio Monforte, Enrico Girardi, et al.
The New Microbiologica|May 20, 2016
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patientsMarco Merli, Laura Galli, Antonella Castagna, et al.
Viruses|March 28, 2026
The Role of Immune Dysregulation Markers in Cardiovascular Risk of People Living with HIV: Association Among Intima Media Changes, CD4/CD8 Ratio, and CD4+ Cell Count NadirManuela Ceccarelli, Elena Delfina Ricci, Camilla Muccini, et al.
Plos One|November 1, 2017
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general populationAntonella Cingolani, Alessandro Cozzi Lepri, Luciana Teofili, et al.
International Journal of Antimicrobial Agents|December 6, 2021
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIVDaniele Armenia, Maria Mercedes Santoro, Maria Concetta Bellocchi, et al.
Drug Design, Development and Therapy|July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical PracticeMartina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Medicine|November 19, 2016
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progressionAntonella Castagna, Laura Monno, Stefania Carta, et al.
Sexually Transmitted Diseases|April 22, 2024
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian CohortMaria Francesca Lucente, Angelo Roberto Raccagni, Laura Galli, et al.
Medicine|July 19, 2016
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patientsFrancesca Ferretti, Alba Bigoloni, Laura Passeri, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2022
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for ImmunizationElena Bruzzesi, Laura Galli, Andrea Poli, et al.
Journal of the International AIDS Society|November 14, 2014
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in ItalyGiordano Madeddu, Antonella D'Arminio Monforte, Enrico Girardi, et al.
The New Microbiologica|May 20, 2016
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patientsMarco Merli, Laura Galli, Antonella Castagna, et al.
Viruses|March 28, 2026
The Role of Immune Dysregulation Markers in Cardiovascular Risk of People Living with HIV: Association Among Intima Media Changes, CD4/CD8 Ratio, and CD4+ Cell Count NadirManuela Ceccarelli, Elena Delfina Ricci, Camilla Muccini, et al.
Plos One|November 1, 2017
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general populationAntonella Cingolani, Alessandro Cozzi Lepri, Luciana Teofili, et al.
International Journal of Antimicrobial Agents|December 6, 2021
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIVDaniele Armenia, Maria Mercedes Santoro, Maria Concetta Bellocchi, et al.
Drug Design, Development and Therapy|July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical PracticeMartina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Medicine|November 19, 2016
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progressionAntonella Castagna, Laura Monno, Stefania Carta, et al.
Sexually Transmitted Diseases|April 22, 2024
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian CohortMaria Francesca Lucente, Angelo Roberto Raccagni, Laura Galli, et al.
Medicine|July 19, 2016
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patientsFrancesca Ferretti, Alba Bigoloni, Laura Passeri, et al.
Pageof 18